Jodie M. Fleming, Ph.D. - Publications

Affiliations: 
2006 Rutgers University, New Brunswick, New Brunswick, NJ, United States 
Area:
Molecular Biology

36 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Jones GS, Hoadley KA, Benefield H, Olsson LT, Hamilton AM, Bhattacharya A, Kirk EL, Tipaldos HJ, Fleming JM, Williams KP, Love MI, Nichols HB, Olshan AF, Troester MA. Racial differences in breast cancer outcomes by hepatocyte growth factor pathway expression. Breast Cancer Research and Treatment. PMID 35034243 DOI: 10.1007/s10549-021-06497-w  0.309
2020 Dixon MS, Chdid L, Lamson DR, Tarpley MT, Oladapo HO, Fleming JM, Freedman JA, Devi GR, Williams KP. Abstract C100: Identification and functional characterization of a novel GLI1 splice variant in breast cancer Cancer Epidemiology, Biomarkers & Prevention. 29. DOI: 10.1158/1538-7755.Disp18-C100  0.366
2019 Yeyeodu ST, Martin ME, Reaves DK, Enders JR, Costantini LM, Fleming JM. Experimental data demonstrating the effects of silver nanoparticles on basement membrane gene and protein expression in cultured colon, mammary and bronchial epithelia. Data in Brief. 26: 104464. PMID 31667234 DOI: 10.1016/J.Dib.2019.104464  0.318
2019 Barrow MA, Martin ME, Coffey A, Andrews PL, Jones GS, Reaves DK, Parker JS, Troester MA, Fleming JM. A functional role for the cancer disparity-linked genes, CRYβB2 and CRYβB2P1, in the promotion of breast cancer. Breast Cancer Research : Bcr. 21: 105. PMID 31511085 DOI: 10.1186/S13058-019-1191-3  0.341
2019 Martin ME, Reaves DK, Jeffcoat B, Enders JR, Costantini LM, Yeyeodu ST, Botta D, Kavanagh TJ, Fleming JM. Silver nanoparticles alter epithelial basement membrane integrity, cell adhesion molecule expression, and TGF-β1 secretion. Nanomedicine : Nanotechnology, Biology, and Medicine. 102070. PMID 31351238 DOI: 10.1016/J.Nano.2019.102070  0.333
2018 Fleming JM, Yeyeodu ST, McLaughlin A, Schuman D, Taylor DK. In situ drug delivery to breast cancer-associated extracellular matrix. Acs Chemical Biology. PMID 30183254 DOI: 10.1021/Acschembio.8B00396  0.313
2018 Barrow MA, Martin ME, Reaves DK, Jeffcoat B, Smith GR, Tarpley M, Williams KP, Fleming JM. Abstract 4058: Race-associated breast cancer disparities: The role of CRYBB2 and its pseudogene Cancer Research. 78: 4058-4058. DOI: 10.1158/1538-7445.Am2018-4058  0.374
2017 Parada H, Sun X, Fleming JM, Williams-DeVane CR, Kirk EL, Olsson LT, Perou CM, Olshan AF, Troester MA. Race-associated biological differences among luminal A and basal-like breast cancers in the Carolina Breast Cancer Study. Breast Cancer Research : Bcr. 19: 131. PMID 29228969 DOI: 10.1186/S13058-017-0914-6  0.334
2017 Oladapo HO, Tarpley M, Sauer SJ, Addo KA, Ingram SM, Strepay D, Ehe BK, Chdid L, Trinkler M, Roques JR, Darr DB, Fleming JM, Devi GR, Williams KP. Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells. Cancer Letters. PMID 28965853 DOI: 10.1016/J.Canlet.2017.09.033  0.473
2016 Reaves DK, Hoadley KA, Fagan-Solis K, Jima DD, Bereman M, Thorpe L, Hicks J, McDonald D, Troester MA, Perou CM, Fleming JM. Nuclear localized LSR, a novel regulator of breast cancer behavior and tumorigenesis. Molecular Cancer Research : McR. PMID 27856957 DOI: 10.1158/1541-7786.Mcr-16-0085-T  0.399
2015 D'Arcy M, Fleming J, Robinson WR, Kirk EL, Perou CM, Troester MA. Race-associated biological differences among Luminal A breast tumors. Breast Cancer Research and Treatment. PMID 26109344 DOI: 10.1007/S10549-015-3474-4  0.326
2015 Reaves DK, Ginsburg E, Bang JJ, Fleming JM. Persistent organic pollutants and obesity: are they potential mechanisms for breast cancer promotion? Endocrine-Related Cancer. 22: R69-86. PMID 25624167 DOI: 10.1530/Erc-14-0411  0.313
2015 Oladapo H, Fleming JM, Addo K, Tarpley M, Ehe B, Ingram S, Sauer S, Devi G, Williams KP. Abstract 680: Identification of GLI1 antagonists for breast cancer therapy Cancer Research. 75: 680-680. DOI: 10.1158/1538-7445.Am2015-680  0.303
2015 Thorpe L, Young J, Troester MA, Fleming JM. Abstract 4020: Identifying the role of CRYBB2 in breast cancer tumor-tumor and tumor-stromal interactions Cancer Research. 75: 4020-4020. DOI: 10.1158/1538-7445.Am2015-4020  0.449
2015 Fagan-Solis KD, McDonald DA, Thorpe LW, Fleming JM. Abstract 1193: LSR transcript variant iota drives nuclear localization and altered transcriptome regulation in breast cancer Cancer Research. 75: 1193-1193. DOI: 10.1158/1538-7445.Am2015-1193  0.384
2014 Fagan-Solis KD, Reaves DK, Rangel MC, Popoff MR, Stiles BG, Fleming JM. Challenging the roles of CD44 and lipolysis stimulated lipoprotein receptor in conveying Clostridium perfringens iota toxin cytotoxicity in breast cancer. Molecular Cancer. 13: 163. PMID 24990559 DOI: 10.1186/1476-4598-13-163  0.409
2014 Reaves DK, Fagan-Solis KD, Dunphy K, Oliver SD, Scott DW, Fleming JM. The role of lipolysis stimulated lipoprotein receptor in breast cancer and directing breast cancer cell behavior. Plos One. 9: e91747. PMID 24637461 DOI: 10.1371/Journal.Pone.0091747  0.414
2014 D'Arcy ME, Robinson WR, Kirk E, Amos KD, Perou CM, Fleming JM, Troester MA. Abstract LB-292: Race-associated gene expression in tumors and breast cancer mortality disparities Cancer Research. 74. DOI: 10.1158/1538-7445.Am2014-Lb-292  0.341
2014 Fleming JM, Reaves DK, Fagan-Solis KD, Dunphy K, Oliver SD. Abstract 1987: The role of lipolysis-stimulated lipoprotein receptor in directing breast cancer cell behavior and subtype Cancer Research. 74: 1987-1987. DOI: 10.1158/1538-7445.Am2014-1987  0.418
2013 Casbas-Hernandez P, D'Arcy M, Roman-Perez E, Brauer HA, McNaughton K, Miller SM, Chhetri RK, Oldenburg AL, Fleming JM, Amos KD, Makowski L, Troester MA. Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ. Breast Cancer Research : Bcr. 15: R82. PMID 24025166 DOI: 10.1186/Bcr3476  0.447
2013 Fleming JM, Ginsburg E, McAndrew CW, Heger CD, Cheston L, Rodriguez-Canales J, Vonderhaar BK, Goldsmith P. Characterization of Δ7/11, a functional prolactin-binding protein. Journal of Molecular Endocrinology. 50: 79-90. PMID 23048206 DOI: 10.1530/Jme-12-0201  0.426
2013 Fleming JM, Ginsburg E, McAndrew C, Heger C, Cheston L, Rodriguez-Canales J, Vonderhaar BK, Paul G. Abstract 528: Characterization of Δ7/11, a functional prolactin-binding protein. Cancer Research. 73: 528-528. DOI: 10.1158/1538-7445.Am2013-528  0.437
2012 Fleming JM, Ginsburg E, Oliver SD, Goldsmith P, Vonderhaar BK. Hornerin, an S100 family protein, is functional in breast cells and aberrantly expressed in breast cancer. Bmc Cancer. 12: 266. PMID 22727333 DOI: 10.1186/1471-2407-12-266  0.369
2012 Fleming JM, Ginsburg E, Goldhar AS, Plant J, Vonderhaar BK. Progesterone receptor activates Msx2 expression by downregulating TNAP/Akp2 and activating the Bmp pathway in EpH4 mouse mammary epithelial cells. Plos One. 7: e34058. PMID 22457812 DOI: 10.1371/Journal.Pone.0034058  0.537
2011 Casbas-Hernandez P, Fleming JM, Troester MA. Gene expression analysis of in vitro cocultures to study interactions between breast epithelium and stroma. Journal of Biomedicine & Biotechnology. 2011: 520987. PMID 22203785 DOI: 10.1155/2011/520987  0.353
2011 Faupel-Badger JM, Ginsburg E, Fleming JM, Susser L, Doucet T, Vonderhaar BK. 16 kDa prolactin reduces angiogenesis, but not growth of human breast cancer tumors in vivo. Hormones & Cancer. 1: 71-9. PMID 21113329 DOI: 10.1007/S12672-010-0012-Z  0.439
2010 Fleming JM, Miller TC, Meyer MJ, Ginsburg E, Vonderhaar BK. Local regulation of human breast xenograft models. Journal of Cellular Physiology. 224: 795-806. PMID 20578247 DOI: 10.1002/Jcp.22190  0.381
2010 Fleming JM, Miller TC, Quinones M, Xiao Z, Xu X, Meyer MJ, Ginsburg E, Veenstra TD, Vonderhaar BK. The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo. Bmc Medicine. 8: 27. PMID 20492690 DOI: 10.1186/1741-7015-8-27  0.352
2010 Meyer MJ, Fleming JM, Lin AF, Hussnain SA, Ginsburg E, Vonderhaar BK. CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer. Cancer Research. 70: 4624-33. PMID 20484027 DOI: 10.1158/0008-5472.Can-09-3619  0.321
2010 Meyer MJ, Fleming JM, Ali MA, Pesesky MW, Ginsburg E, Vonderhaar BK. Abstract 4308: Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines Cancer Research. 70: 4308-4308. DOI: 10.1158/1538-7445.Am10-4308  0.398
2010 Fleming JM, Miller TC, Quinones M, Xiao Z, Xu X, Meyer MJ, Ginsburg E, Veenstra TD, Vonderhaar BK. Abstract 3845: The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo Cancer Research. 70: 3845-3845. DOI: 10.1158/1538-7445.Am10-3845  0.376
2009 Meyer MJ, Fleming JM, Ali MA, Pesesky MW, Ginsburg E, Vonderhaar BK. Dynamic regulation of CD24 and the invasive, CD44posCD24neg phenotype in breast cancer cell lines. Breast Cancer Research : Bcr. 11: R82. PMID 19906290 DOI: 10.1186/Bcr2449  0.394
2007 Fleming JM, Brandimarto JA, Cohick WS. The mitogen-activated protein kinase pathway tonically inhibits both basal and IGF-I-stimulated IGF-binding protein-5 production in mammary epithelial cells. The Journal of Endocrinology. 194: 349-59. PMID 17641284 DOI: 10.1677/Joe-06-0121  0.769
2006 Fleming JM, Desury G, Polanco TA, Cohick WS. Insulin growth factor-I and epidermal growth factor receptors recruit distinct upstream signaling molecules to enhance AKT activation in mammary epithelial cells. Endocrinology. 147: 6027-35. PMID 16990343 DOI: 10.1210/En.2006-0349  0.618
2005 Fleming JM, Leibowitz BJ, Kerr DE, Cohick WS. IGF-I differentially regulates IGF-binding protein expression in primary mammary fibroblasts and epithelial cells. The Journal of Endocrinology. 186: 165-78. PMID 16002546 DOI: 10.1677/Joe.1.06164  0.72
2004 Sivaprasad U, Fleming J, Verma PS, Hogan KA, Desury G, Cohick WS. Stimulation of insulin-like growth factor (IGF) binding protein-3 synthesis by IGF-I and transforming growth factor-alpha is mediated by both phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways in mammary epithelial cells. Endocrinology. 145: 4213-21. PMID 15192040 DOI: 10.1210/En.2003-1377  0.645
Show low-probability matches.